Theravance Biopharma Inc (TBPH)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.88B
EV to revenue ratio (TTM)
5.13
EV to ebitda
8.60
Financial Performance
Revenue (TTM)
$0.10B
Gross profit (TTM)
$0.08B
EBITDA
$0.01B
Profitability
Operating margin (TTM)
8.89%
Profit margin
51.60%
Return on assets (TTM)
1.33%
Return on equity (TTM)
20.90%
Per Share Metrics
Revenue per share (TTM)
$2.04
EPS
$1.04
Diluted EPS (TTM)
$1.04
Book value
$5.58
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
16.38
Trailing P/E
16.38
Forward P/E
9.73
PEG ratio
-0.05
Price to sales ratio (TTM)
8.48
Price to book ratio (TTM)
3.05
Growth
Quarterly earnings growth (YoY)
-20.90%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
0
Hold
5
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.25